Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?

被引：42

作者：

Rai, Mahendra ^{[1
,2
]}

Ingle, Avinash P. ^{[3
]}

Trzcinska-Wencel, Joanna ^{[1
]}

Wypij, Magdalena ^{[1
]}

Bonde, Shital ^{[2
]}

Yadav, Alka ^{[2
]}

Kratosova, Gabriela ^{[4
]}

Golinska, Patrycja ^{[1
]}

机构：

[1] Nicolaus Copernicus Univ Torun, Fac Biol & Vet Sci, Lwowska 1, PL-87100 Torun, Poland

[2] St Gadge Baba Amravati Univ, Dept Biotechnol, Amravati 444602, India

[3] Dr Panjabrao Deshmukh Krishi Vidyapeeth, Dept Agr Bot, Biotechnol Ctr, Akola 444104, India

[4] VSB Tech Univ Ostrava, Nanotechnol Ctr, CEET, 17 Listopadu 2172-15, Ostrava 70800, Czech Republic

来源：

NANOMATERIALS | 2021年 / 11卷 / 11期

关键词：

silver nanoparticles; biosynthesis; application; biodistribution; toxicity; GREEN SYNTHESIS; ANTIBACTERIAL ACTIVITY; MEDIATED SYNTHESIS; ANTIMICROBIAL ACTIVITY; METAL NANOPARTICLES; RAPID SYNTHESIS; EXTRACELLULAR BIOSYNTHESIS; BIOLOGICAL SYNTHESIS; BIOMIMETIC SYNTHESIS; CULTURE SUPERNATANT;

D O I：

10.3390/nano11112901

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Nanobiotechnology is considered to be one of the fastest emerging fields. It is still a relatively new and exciting area of research with considerable potential for development. Among the inorganic nanomaterials, biogenically synthesized silver nanoparticles (bio-AgNPs) have been frequently used due to their unique physicochemical properties that result not only from their shape and size but also from surface coatings of natural origin. These properties determine antibacterial, antifungal, antiprotozoal, anticancer, anti-inflammatory, and many more activities of bio-AgNPs. This review provides the current state of knowledge on the methods and mechanisms of biogenic synthesis of silver nanoparticles as well as their potential applications in different fields such as medicine, food, agriculture, and industries.

引用

页数：34

共 50 条

[1] What do we know? What do we need to know?
Milena J. Henzlova
W. Lane Duvall
[J]. Journal of Nuclear Cardiology, 2017, 24 : 252 - 254
[2] What do we know? What do we need to know?
Henzlova, Milena J.
Duvall, W. Lane
[J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (01) : 252 - 254
[3] Diversity: What We Know, What We Need to Know, and What We Need to Do
Dukes, Charles
Lamar-Dukes, Pamela
[J]. RESEARCH AND PRACTICE FOR PERSONS WITH SEVERE DISABILITIES, 2009, 34 (3-4) : 71 - 75
[4] Erratum to: What do we know? What do we need to know?
Milena J. Henzlova
W. Lane Duvall
[J]. Journal of Nuclear Cardiology, 2017, 24 (1) : 255 - 255
[5] Syphilis and blood donors: What we know, what we do not know, and what we need to know
Orton, S
[J]. TRANSFUSION MEDICINE REVIEWS, 2001, 15 (04) : 282 - 291
[6] What do we know, what do we need to know and how do we apply it?
Lawrence, G.
[J]. RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S37 - S37
[7] Food OIT What do we know, what don't we know, and what do we need to know?
Ciaccio, Christina E.
Bauer, Maureen Egan
Nowak-Wegrzyn, Anna
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (02) : 118 - 119
[8] Zebrafish and steroids: What do we know and what do we need to know?
Tokarz, Janina
Moeller, Gabriele
de Angelis, Martin Hrabe
Adamski, Jerzy
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 137 : 165 - 173
[9] Managing dyspepsia: What do we know and what do we need to know?
Rabeneck, L
Wray, NP
Graham, DY
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (06): : 920 - 924
[10] Fear of falling: What do we know, what do we need to know?
Lach, HW
[J]. GERONTOLOGIST, 2001, 41 : 387 - 387

← 1 2 3 4 5 →